Analyzing the medical use of cannabis for cancer patients: a critical perspective

Simple item page
dc.contributor.authorPatel, R.en_US
dc.contributor.authorPatel, M.en_US
dc.contributor.authorPatel, Z.en_US
dc.contributor.authorKavani, H.en_US
dc.contributor.authorPatel, D.en_US
dc.contributor.authorShaikh, S.en_US
dc.date.accessioned2024-09-24T06:57:53Z
dc.date.available2024-09-24T06:57:53Z
dc.date.issued2024-03
dc.description.abstractThe utilization of cannabis in oncology presents a multifaceted approach to addressing the complex challenges associated with cancer treatment. With roots tracing back to ancient medicinal practices, cannabis contains numerous compounds, including cannabinoids like tetrahydrocannabinol (THC) and cannabidiol (CBD), that interact with the body's endocannabinoid system. These interactions offer potential therapeutic benefits, ranging from antiemetic and analgesic effects to the inhibition of cancer growth processes. While clinical evidence supports the efficacy of cannabinoids in managing symptoms and enhancing the quality of life for cancer patients, caution is warranted due to potential interactions with conventional medications. Understanding the mechanisms of action, optimal administration routes, and potential side effects is crucial for integrating cannabis into personalized cancer care plans. By navigating these considerations thoughtfully, medical practitioners can harness the therapeutic potential of cannabis to complement traditional cancer treatments and improve patient outcomes in the field of oncology.en_US
dc.identifier.affiliationsDepartment of Internal Medicine, Community Hospital of San Bernardino, CA, USAen_US
dc.identifier.affiliationsDepartment of Internal Medicine, Trumbull Regional Medical Center, OH, USAen_US
dc.identifier.affiliationsDepartment of Internal Medicine, University of California Riverside, CA, USAen_US
dc.identifier.affiliationsDepartment of Internal Medicine, Geisinger Community Medical Center, PA, USAen_US
dc.identifier.affiliationsClinical Research Program, Rush University, IL, USAen_US
dc.identifier.affiliationsDepartment of Internal Medicine, Washington University, MO, USAen_US
dc.identifier.citationPatel R., Patel M., Patel Z., Kavani H., Patel D., Shaikh S.. Analyzing the medical use of cannabis for cancer patients: a critical perspective. International Journal of Community Medicine and Public Health. 2024 Mar; 11(3): 1349-1354en_US
dc.identifier.issn2394-6032
dc.identifier.issn2394-6040
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/227905
dc.languageenen_US
dc.publisherMedip Academyen_US
dc.relation.issuenumber3en_US
dc.relation.volume11en_US
dc.source.urihttps://doi.org/10.18203/2394-6040.ijcmph20240644en_US
dc.subjectCannabisen_US
dc.subjectCannabinoidsen_US
dc.subjectCancer treatmenten_US
dc.subjectTHCen_US
dc.subjectCBDen_US
dc.subjectSymptom managementen_US
dc.subjectPharmacological interactionsen_US
dc.subjectAdministration routesen_US
dc.subjectOncologyen_US
dc.titleAnalyzing the medical use of cannabis for cancer patients: a critical perspectiveen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijcmph2024v11n3p1349.pdf
Size:
355.47 KB
Format:
Adobe Portable Document Format
Download
Collections
International Journal of Community Medicine and Public Health